BRAIN Biotech AG reported earnings results for the full year ended September 30, 2025. For the full year, the company reported sales was EUR 49.62 million compared to EUR 54.63 million a year ago. Revenue was EUR 51.59 million compared to EUR 55.52 million a year ago.
Net loss was EUR 11.74 million compared to EUR 11.13 million a year ago. Basic loss per share from continuing operations was EUR 0.54 compared to EUR 0.51 a year ago. Diluted loss per share from continuing operations was EUR 0.54 compared to EUR 0.51 a year ago.
